META, ELDA
 Distribuzione geografica
Continente #
EU - Europa 1.066
AS - Asia 160
NA - Nord America 95
SA - Sud America 8
AF - Africa 3
Totale 1.332
Nazione #
IT - Italia 1.037
US - Stati Uniti d'America 93
SG - Singapore 70
CN - Cina 37
VN - Vietnam 34
FI - Finlandia 6
HK - Hong Kong 6
FR - Francia 5
GB - Regno Unito 5
DE - Germania 4
ID - Indonesia 4
AR - Argentina 3
BR - Brasile 3
IE - Irlanda 2
IN - India 2
JP - Giappone 2
MX - Messico 2
NL - Olanda 2
RU - Federazione Russa 2
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
ES - Italia 1
IQ - Iraq 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
MA - Marocco 1
PE - Perù 1
TH - Thailandia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 1.332
Città #
Genova 437
Genoa 374
Rapallo 123
Vado Ligure 99
Singapore 33
San Jose 27
Ashburn 26
Hanoi 10
Ho Chi Minh City 7
Council Bluffs 6
Helsinki 6
Hong Kong 5
Santa Clara 5
Frankfurt am Main 4
Lauterbourg 4
Cardiff 3
Haiphong 3
New York 3
Amsterdam 2
Beijing 2
Dublin 2
Los Angeles 2
Lấp Vò 2
The Dalles 2
Tokyo 2
Algiers 1
Amman 1
Atlanta 1
Basingstoke 1
Bishkek 1
Biên Hòa 1
Bojonegoro 1
Bordighera 1
Buffalo 1
Buon Ma Thuot 1
Bình Phước 1
Bắc Ninh 1
Calchaquí 1
Casablanca 1
Chiclayo 1
City of London 1
Copenhagen 1
Des Moines 1
Durban 1
Greenville 1
Guadalupe 1
Hải Dương 1
Itajaí 1
Khabarovsk 1
Lagoa da Prata 1
Lviv 1
Marcianise 1
Medellín 1
Mexico City 1
Mosul 1
Nawanshahr 1
Ninh Bình 1
Nova Olímpia 1
Patiāla 1
San Luis 1
Surabaya 1
Tasikmalaya 1
Tianjin 1
Torre Annunziata 1
Torrijos 1
Tây Ninh 1
Villa Ángela 1
Winston-Salem 1
Totale 1.232
Nome #
The pyrazolyl-urea GeGe3 inhibits tumor angiogenesis and reveals dystrophia myotonica protein Kinase (DMPK)1 as a novel angiogenesis target 177
Pyrazole and imidazo[1,2-b]pyrazole derivatives as new potential anti-tuberculosis agents. 156
3-Cyclopentyloxy-4-Methoxyphenyl-isoxazoline derivatives as new PDE4 inhibitors. 147
Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma 142
Design, synthesis and biological evaluation of new pyrazolyl-ureas and imidazopyrazolecarboxamides able to interfere with MAPK and PI3K upstream signaling involved in the angiogenesis 141
Development of imidazo-pyrazole derivatives as potential antimetastatic agents in neuroblastoma 114
The kinase inhibitor pyrazolyl-urea GeGe3 inhibits angiogenesis and reveals dystrophia myotonica protein kinase (DMPK)1 as a novel angiogenesis target 108
New series of pyrazoles and imidazo‐pyrazoles targeting different cancer and inflammation pathways 92
The Kinase Inhibitor Pyrazolyl-Urea Gege3 Inhibits Angiogenesis And Reveals Dystrophia Myotonica Protein Kinase (DMPK)1 As A Novel Angiogenesis Target 89
Erratum: Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma (Oncotarget) 72
New kinases targeted compounds as possible antiangiogenic and antimetastatic agents 70
Synthesis, functional proteomics and biological evaluation of new 5-pyrazolyl ureas as potential anti-angiogenic compounds 50
null 18
Totale 1.376
Categoria #
all - tutte 5.010
article - articoli 3.884
book - libri 0
conference - conferenze 1.126
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.020


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 0 0 8 4 1
2021/2022115 10 5 2 8 4 8 2 33 13 15 0 15
2022/2023149 11 17 2 22 20 18 0 13 14 0 27 5
2023/202489 4 14 2 15 19 9 5 2 2 4 2 11
2024/2025269 4 25 3 26 29 21 24 46 11 11 31 38
2025/2026399 57 9 18 25 82 29 67 37 35 40 0 0
Totale 1.376